Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

House GOP unveils healthcare plan ahead of vote next week as cost hike looms for millions

by admin December 13, 2025
December 13, 2025
House GOP unveils healthcare plan ahead of vote next week as cost hike looms for millions

House Republicans have released a 111-page plan for reforming healthcare that they hope to vote on next week.

House GOP leadership aides also told reporters on Friday afternoon that they expected a vote on extending enhanced Obamacare subsidies to also happen next week as part of the amendment process to the final bill, called the ‘Lower Health Care Premiums for All Americans Act.’ The subsidies have been the subject of fierce inter-party debate for Republicans.

‘We expect that there will be an amendment that I believe is being worked on, so the process will allow for that amendment,’ aides said.

The plan as-is includes provisions to codify association health plans, which allow small businesses and people who are self-employed to band together to purchase healthcare coverage plans, giving them access to greater bargaining power.

Republicans also plan to appropriate funding for cost-sharing reductions beginning in 2027, which are designed to lower out-of-pocket medical costs in the individual healthcare market. House GOP leadership aides said it would bring down the cost of premiums by 12%.

New transparency requirements for pharmacy benefit managers (PBMs) are also in the legislation, aimed at forcing PBMs to be more upfront about costs to employers.

PBMs are third parties that act as intermediaries between pharmaceutical companies and those responsible for insurance coverage, often responsible for administrative tasks and negotiating drug prices.

PBMs have also been the subject of bipartisan ire in Congress, with both Republicans and Democrats accusing them of being part of a broken system to inflate health costs.

But the most divisive measure for Republicans is likely not yet fleshed out. 

A majority of House Republicans are against extending the enhanced Obamacare subsidies, which were designed to get affordable health insurance for more Americans during the COVID-19 pandemic.

Democrats voted to pass the enhanced subsidies in 2021 and extended them through 2022 when they controlled Congress.

A group of moderate House Republicans has joined Democrats now in vehemently pushing for those subsidies to be extended again, as millions of Americans face near-certain healthcare price hikes beginning in January.

Two separate bipartisan efforts have been launched to force a vote on extending the subsidies in some form. But any such push would require support from virtually all House Democrats to succeed, and their leaders have not given their blessing to either plan.

‘We’re going to evaluate every single good faith proposal. But it has to meaningfully provide certainty to the American people who are at risk of having their health care ripped away from them,’ House Minority Leader Hakeem Jeffries, D-N.Y., told reporters on Friday.

But conservatives have warned they would not support any such extension unless paired with significant reforms to what they view as a long-broken system that fuels healthcare price inflation.

‘I think that would be a disastrous plan. I mean, we’ve clearly seen that Obamacare is the Titanic. It’s going down. I think throwing money after it is just going to be wasteful,’ House Freedom Caucus member Rep. Eric Burlison, R-Mo., told Fox News’ Chad Pergram on Friday.

This post appeared first on FOX NEWS

previous post
Cruz says Rep Ilhan Omar could face jail time, deportation if marriage allegation proves true
next post
Preservation group sues Trump administration over White House ballroom project

related articles

House Freedom Caucus targets Trump’s ‘big, beautiful bill’...

July 1, 2025

Netanyahu to testify in corruption trial amid multiple...

December 9, 2024

Trump DOJ opens mortgage fraud probe into Eric...

November 14, 2025

Schumer refuses to step down as Senate Dem...

March 24, 2025

Federal appeals court upholds $83.3M E. Jean Carroll...

September 9, 2025

Dem rep opens House hearing by telling Noem...

December 12, 2025

RFK Jr attributes rise in autism to environmental...

April 17, 2025

US military to oversee next phase of peace...

October 16, 2025

All eyes on Russia-Ukraine as Trump kicks off...

February 17, 2025

Germany accuses Elon Musk of trying to interfere...

December 31, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 2

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 3

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024
    • 4

      Lode Gold Launches Exploration Program at One of the Largest Land Packages in New Brunswick

      October 19, 2024
    • 5

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024

    Categories

    • Investing (3,119)
    • Latest News (2,300)
    • Politics (3,725)
    • Stocks (1,130)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved